Extendicare Inventory Turnover from 2010 to 2024

EXE Stock  CAD 10.64  0.13  1.24%   
Extendicare Inventory Turnover yearly trend continues to be very stable with very little volatility. Inventory Turnover is likely to grow to 400.51 this year. Inventory Turnover is a ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management. View All Fundamentals
 
Inventory Turnover  
First Reported
2010-12-31
Previous Quarter
381.44
Current Value
400.51
Quarterly Volatility
177.85281939
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Extendicare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Extendicare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 45.5 M, Interest Expense of 20.5 M or Total Revenue of 1.3 B, as well as many indicators such as Price To Sales Ratio of 0.43, Dividend Yield of 0.0746 or PTB Ratio of 7.29. Extendicare financial statements analysis is a perfect complement when working with Extendicare Valuation or Volatility modules.
  
This module can also supplement various Extendicare Technical models . Check out the analysis of Extendicare Correlation against competitors.

Pair Trading with Extendicare

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Extendicare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extendicare will appreciate offsetting losses from the drop in the long position's value.

Moving together with Extendicare Stock

  0.76BRK Berkshire Hathaway CDRPairCorr
  0.82JPM JPMorgan ChasePairCorr
  0.85BOFA Bank of AmericaPairCorr

Moving against Extendicare Stock

  0.86PFE Pfizer Inc CDRPairCorr
The ability to find closely correlated positions to Extendicare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Extendicare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Extendicare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Extendicare to buy it.
The correlation of Extendicare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Extendicare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Extendicare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Extendicare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Extendicare Stock

Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.